|
ZNHIT3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.222410E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.193220E-01 |
| Normal-vs-Stage2 |
6.107000E-01 |
| Normal-vs-Stage3 |
7.125600E-02 |
| Normal-vs-Stage4 |
4.407900E-02 |
| Stage1-vs-Stage2 |
5.062000E-01 |
| Stage1-vs-Stage3 |
5.705000E-01 |
| Stage1-vs-Stage4 |
2.982600E-01 |
| Stage2-vs-Stage3 |
2.973200E-01 |
| Stage2-vs-Stage4 |
1.913240E-01 |
| Stage3-vs-Stage4 |
5.428600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.405900E-02 |
| Normal-vs-AfricanAmerican |
8.760800E-01 |
| Normal-vs-Asian |
1.749810E-01 |
| Caucasian-vs-AfricanAmerican |
2.873200E-01 |
| Caucasian-vs-Asian |
7.029000E-01 |
| AfricanAmerican-vs-Asian |
4.763800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.024430E-01 |
| Normal-vs-Female |
9.278200E-02 |
| Male-vs-Female |
7.879000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.147840E-01 |
| Normal-vs-Age(41-60Yrs) |
1.915240E-01 |
| Normal-vs-Age(61-80Yrs) |
8.020100E-02 |
| Normal-vs-Age(81-100Yrs) |
9.347400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.733400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.062800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.739600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.031600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.500400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.458400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.028000E-01 |
| Classical-VS-Follicular |
3.510600E-01 |
| Classical-VS-Other |
6.900800E-01 |
| Classical-VS-Normal |
8.726500E-02 |
| Tall-VS-Follicular |
2.554800E-01 |
| Tall-VS-Other |
5.489000E-01 |
| Tall-VS-Normal |
8.718300E-02 |
| Follicular-VS-Other |
9.885800E-01 |
| Follicular-VS-Normal |
6.118200E-01 |
| Other-VS-Normal |
7.725000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.356400E-01 |
| Normal-vs-N1 |
1.062150E-03 |
| N0-vs-N1 |
5.741700E-03 |
|
|
